Latest News

Bakkt Holdings recently completed the sale of its loyalty business and appointed fintech veteran Mike Alfred to its board, marking a shift to a focused digital asset infrastructure platform. This transformation is underscored by renewed emphasis on Bitcoin, tokenized payments, and zero debt, signaling a significant realignment toward crypto and digital finance services. We'll explore how the company’s sharpened focus on digital assets and new leadership shapes Bakkt Holdings' investment...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Alto Neuroscience just received Fast Track designation from the FDA for ALTO-101, a new drug candidate aimed at treating cognitive impairment related to schizophrenia. This move could accelerate ALTO-101’s development and review process. See our latest analysis for Alto Neuroscience. The FDA’s support for ALTO-101 sparked fresh interest in Alto Neuroscience. However, despite the headline, its 1-year total shareholder return remains nearly flat while recent share price momentum has been...

If you are wrestling with the question of what to do with JD Logistics stock right now, you are not alone. Shares closed at 12.89 in the latest session and while the company's price hasn’t exactly skyrocketed lately, there are clear signals that the market's perception is quietly shifting. Over the last seven days, the stock notched a 0.5% gain. Over thirty days, it's up by 1.5%, and so far this year, JD Logistics has inched forward by 1.7%. Yet, if we zoom out, the one-year performance...

Are you eyeing Voestalpine and wondering if now is your moment to invest, hold, or walk away? You're not alone. After a year of eye-catching gains, this stock has many talking, and for good reason. Voestalpine has soared an impressive 81.7% year-to-date, with the past 30 days alone bringing investors a robust 15.2% return. Even looking beyond the short term, the stock is up nearly 100% over three years and 63.9% over five years. These moves hint at renewed optimism but may also reflect shifts...

Yunfeng Financial Group (SEHK:376) has just been added to the S&P Global BMI Index, an event that often attracts the attention of investors and index funds. Index inclusions like this can generate new trading interest and increase liquidity. See our latest analysis for Yunfeng Financial Group. Shares have gained momentum following the S&P Global BMI Index inclusion, with a recent share price return of 5.1% year-to-date and a steady 3.7% total shareholder return over the past year, which hints...

As the Australian market experiences a slight pullback following a bullish surge, investors are keenly observing the ASX 200's movements amidst fluctuating global economic factors such as U.S. government shutdown concerns and rising gold prices. In this context, identifying undervalued stocks can be particularly appealing, as they may offer potential opportunities for growth in a market that is currently experiencing volatility and consolidation.

Thinking about what to do with Informatica stock? You are not alone. Recent movement in the shares has caught a lot of attention, and there is no shortage of opinions out there. Right now, the stock is hovering near $24.92, and you might notice the numbers are a bit of a mixed bag. Over the past week and month, Informatica has inched up by 0.4% and 0.6% respectively, but if you look at the year-to-date performance, it is down 2.1%. The past year also shows a slight dip, with shares falling...

ClearPoint Neuro recently announced the appointment of Dr. Paul Larson as Chief Medical Officer, the unveiling of its proprietary Robotic Neuro-Navigation System for minimally invasive cranial procedures, and new insider buying from directors. The Robotic Neuro-Navigation System aims to provide greater consistency for cell and gene therapy delivery, and ClearPoint's drug delivery technology was spotlighted in strong Huntington's disease trial results from a biopharma collaborator. Let's...

Bravura Solutions (ASX:BVS) shares are drawing fresh interest after the company raised its annual revenue and profit outlook and named a new CEO. These moves suggest shifting momentum and evolving leadership. See our latest analysis for Bravura Solutions. Bravura’s latest leadership shake-up and raised guidance have prompted the shares to touch fresh 12-month highs, supported by a stronger British pound and improved project revenue in EMEA. While the one-year total shareholder return is just...

Reitar Logtech Holdings recently announced the formal signing of a Strategic Cooperation Memorandum of Understanding with AI logistics company NEXX to jointly invest in a Smart Fulfillment Center project in Doha, Qatar, as part of broad plans for logistics automation in the region. This initiative not only launches a large-scale, AI-driven logistics facility but also aligns with Qatar's 2030 National Vision and the digital corridor ambitions of China's Belt and Road Initiative. We'll explore...

Thinking about what to do with Eutelsat Communications stock? You are not alone. All eyes are on the company after a dramatic resurgence in its share price, and with some big valuation questions still on the table, it is the kind of moment that makes both new investors and seasoned holders pause for a closer look. Over the last week, Eutelsat saw its share price climb 10.7%. Stretch that view out to one month, and the return balloons to 31.1%, fuelled by renewed optimism about satellite...

Trying to decide what to do with Konica Minolta? You are definitely not alone. With the stock closing at 527.6, it has been a fascinating year for shareholders and new investors alike. After years of rebuilding its core business, Konica Minolta is once again on investors’ radars, and for good reason. Despite some recent turbulence as the stock dipped -2.7% over the last week, those who have looked further back will notice some remarkable momentum. Year to date, the price has fallen -18.1%,...

With a price-to-earnings (or "P/E") ratio of 9.7x Green Brick Partners, Inc. ( NYSE:GRBK ) may be sending bullish...

With a median price-to-sales (or "P/S") ratio of close to 2.8x in the Medical Equipment industry in the United States...

The Glimpse Group, Inc. ( NASDAQ:VRAR ) shareholders would be excited to see that the share price has had a great...

Anyone interested in Amylyx Pharmaceuticals, Inc. ( NASDAQ:AMLX ) should probably be aware that the Co-Founder, Justin...

We wouldn't blame Snowflake Inc. ( NYSE:SNOW ) shareholders if they were a little worried about the fact that Vivek...

We can readily understand why investors are attracted to unprofitable companies. For example, although...

Over the last year, a good number of insiders have significantly increased their holdings in Neurogene Inc...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Blue Bird fair value estimate is US$94.98 Blue Bird is...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Key Insights Institutions' substantial holdings in Rayonier Advanced Materials implies that they have significant...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Stitch Fix fair value estimate is US$6.57 Stitch Fix is...